StockData
Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc. (XLO) stock

XLONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3080% below fair value
$7.63+0.09 (+1.19%)

Close on Nov 18, 2026Market cap $44.12MP/E –Yield –

Xilio Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Xilio Therapeutics's market cap was $55.73M on Nov 11, 2026, against $39.26M a year earlier. Over the last 5 years it ranged from $10.60M to $322.28M, with a median of $48.92M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$55.73M+68.0%
2025Dec 31, 2025$33.18M-21.0%
2024Dec 31, 2024$41.98M+177.3%
2023Dec 29, 2023$15.14M-79.5%
2022Dec 30, 2022$73.72M+491.5%
2021Dec 31, 2021$12.46M–

More Xilio Therapeutics figures

See a number that looks wrong?